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BACKGROUND 
•  Barrett’s esophagus (BE) is defined as metaplasia of 
the esophageal epithelium resulting in the 
replacement of normal squamous epithelium by 
columnar epithelium. 
•  It is associated with gastroesophageal reflux  
disease (GERD). 
•  Patients with BE are at increased risk of developing 
esophageal adenocarcinoma and require close 
monitoring. 
•  Management of BE has changed remarkably with the 
introduction of endoscopic thermal ablative therapies 
that include  radiofrequency ablation (RFA) and 
argon-plasma coagulation (APC).
•  Both therapies are associated with risk of stricture 
formation (5–10%) and APC increases the risk of 
buried metaplastic glands under the neosquamous 
epithelium. 
•  To overcome these detrimental effects of both 
therapies, a novel hybrid ablation method that 
combines APC and submucosal saline injection called 
Hybrid APC has been developed that has shown to 
decrease the rate of these complications by creating 
a submucosal fluid cushion prior to ablation. 
•  We present two cases where employment of Hybrid 
APC resulted in the eradication of BE following 
endoscopic mucosal resection (EMR) and multiple 
RFA therapies.
CASE 1
•  A 62 year old male diagnosed with BE, 
long segment with HGD and intramucosal 
adenocarcinoma status post EMR four 
years back was closely monitored with 
surveillance EGD and subsequently 
underwent EMR three times, and RFA 
eight times with disease persistence.
•  Patient was deemed to be a high risk 
candidate for surgery. 
•  Hybrid APC was performed resulting in 
significant macroscopic and histologic 
remission following therapy. (Image 2)
•  Patient continues to be followed up  
closely with no disease recurrence
CASE 2
•  A 62 year old male diagnosed with BE, 
long segment with HGD and intramucosal 
adenocarcinoma status post EMR four 
years back was closely monitored with 
surveillance EGD and subsequently 
underwent EMR three times, and RFA 
eight times with disease persistence.
•  Patient was deemed to be a high risk 
candidate for surgery. 
•  Hybrid APC was performed resulting in 
significant macroscopic and histologic 
remission following therapy. (Image 4)
•  Patient continues to be followed up closely 
with no disease recurrence
DISCUSSION
•  Hybrid APC is a new novel 
treatment modality shown to 
be effective and safe in the 
management of BE. 
•  Manner et.al showed macro-
scopically complete remission 
(CR) in 46 of the 48 patients 
and histologically CR out of 
46 patients from BE. 
•  Further multicenter prospective 
trials are required to study 
this promising new technique 
compared to other treatment 
techniques.
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CASE 1
Image 1: EGD showing persistent BE prior to Hybrid APC 
Image 2: EGD shows Irregular Z line following Hybrid APC
CASE 2
Image 3:  EGD showing salmon colored mucosa extending up from the 
top of the gastric folds
Image 4: EGD Smooth, round Z-line
